|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/18 | (2006.01) |
| C07K 16/18 | (2013.01) | ||
| G01N 33/50 | (2006.01) | ||
| C07K2317/24 | (2013.01) | ||
| G01N 33/68 | (2006.01) | ||
| C07K2317/34 | (2013.01) | ||
| A61P 3/06 | (2006.01) | ||
| C07K2317/55 | (2013.01) | ||
| C07K2317/565 | (2013.01) | ||
| A61P 9/10 | (2006.01) | ||
| A61P 25/00 | (2006.01) | ||
| C07K2317/76 | (2013.01) | ||
| A61P 25/28 | (2006.01) | ||
| C07K2317/92 | (2013.01) | ||
| A61P 43/00 | (2006.01) | ||
| G01N 33/6896 | (2013.01) | ||
| G01N2333/4709 | (2013.01) | ||
| G01N2800/2814 | (2013.01) | ||
| G01N2800/2821 | (2013.01) | ||
| G01N 33/5058 | (2013.01) | ||
| A61P 25/00 | (2018.01) | ||
| A61P 25/28 | (2018.01) | ||
| A61P 3/06 | (2018.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61P 9/10 | (2018.01) |
| (11) | Number of the document | 1812062 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05820737.4 |
| Date of filing the European patent application | 2005-10-21 | |
| (97) | Date of publication of the European application | 2007-08-01 |
| (45) | Date of publication and mention of the grant of the patent | 2022-03-09 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2005/038125 |
| Date | 2005-10-21 |
| (87) | Number | WO 2006/055178 |
| Date | 2006-05-26 |
| (30) | Number | Date | Country code |
| 621776 P | 2004-10-25 | US | |
| 652538 P | 2005-02-14 | US |
| (72) |
ACTON, Paul , US
AN, Zhiqiang , US
BETT, Andrew, J. , US
BREESE, Robert , US
DODSON, Elizabeth, Chen , US
KINNEY, Gene , US
KLEIN, William , US
LAMBERT, Mary, P. , US
LIANG, Xiaoping , US
SHUGHRUE, Paul , US
STROHL, William, R. , US
VIOLA, Kirsten, L. , US
CHANG, Lei , US
|
| (73) |
Merck Sharp & Dohme Corp. ,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
Northwestern University , 633 Clark Street, Evanston, IL 60208, US |
| (54) | ANTI-ADDL ANTIBODIES AND USES THEREOF |
| ANTI-ADDL ANTIBODIES AND USES THEREOF |